SI-Bone (NASDAQ: SIBN) revenue
SI-Bone reported revenue of $200.9m for fiscal 2025, 20.2% more than in fiscal 2024 ($167.2m). Since fiscal 2017 its revenue has grown by 318.7%, an average growth of 19.6% a year.
SI-Bone has grown its revenue for 8 years in a row, and fiscal 2025 is the highest of its 9 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $200.9m | +20.2% | −$22.3m | −11.1% |
| 2024 | $167.2m | +20.4% | −$35.2m | −21.1% |
| 2023 | $138.9m | +30.5% | −$46.9m | −33.8% |
| 2022 | $106.4m | +18.0% | −$59.6m | −56.0% |
| 2021 | $90.2m | +22.8% | −$51.7m | −57.3% |
| 2020 | $73.4m | +9.0% | −$38.6m | −52.6% |
| 2019 | $67.3m | +21.5% | −$36.0m | −53.5% |
| 2018 | $55.4m | +15.4% | −$12.0m | −21.6% |
| 2017 | $48.0m | — | −$17.4m | −36.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
SI-Bone revenue compared with its sector
By revenue for its latest fiscal year, SI-Bone ranks 248th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; SI-Bone, 20.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 246th | Establishment Labs | $211.1m | 27.1% |
| 247th | Cytek Biosciences | $201.5m | 0.5% |
| 248th | SI-Bone | $200.9m | 20.2% |
| 249th | Strata Critical Medical | $197.1m | 34.3% |
| 250th | LifeMD | $194.1m | 25.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of SI-Bone
- How much revenue did SI-Bone make in fiscal 2025?
- SI-Bone reported revenue of $200.9m for fiscal 2025, compared with $167.2m in fiscal 2024.
- How much has the revenue of SI-Bone grown?
- Between fiscal 2017 and fiscal 2025 it went from $48.0m to $200.9m: 318.7% more, an average growth of 19.6% a year.
- What was the best year for revenue at SI-Bone?
- Of its last 9 fiscal years, fiscal 2025, with $200.9m.
- Where does SI-Bone rank in its sector by revenue?
- It ranks 248th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for SI-Bone come from?
- From the annual report (Form 10-K) that SI-Bone files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that SI-Bone files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on SI-Bone: the SI-Bone page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.